0001520138-23-000533.txt : 20231206
0001520138-23-000533.hdr.sgml : 20231206
20231206161606
ACCESSION NUMBER: 0001520138-23-000533
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231109
FILED AS OF DATE: 20231206
DATE AS OF CHANGE: 20231206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROGICH SIGMUND
CENTRAL INDEX KEY: 0001168218
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39015
FILM NUMBER: 231469793
MAIL ADDRESS:
STREET 1: C/O BIOVIE
STREET 2: 2120 COLORADO AVENUE, SUITE 230
CITY: SANTA MONICA
STATE: CA
ZIP: 90404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOVIE INC.
CENTRAL INDEX KEY: 0001580149
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462510769
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 680 W NYE LANE
STREET 2: SUITE 201
CITY: CARSON CITY
STATE: NV
ZIP: 89703
BUSINESS PHONE: 775-888-3162
MAIL ADDRESS:
STREET 1: 680 W NYE LANE
STREET 2: SUITE 201
CITY: CARSON CITY
STATE: NV
ZIP: 89703
FORMER COMPANY:
FORMER CONFORMED NAME: NANOANTIBIOTICS, INC.
DATE OF NAME CHANGE: 20130625
4
1
ownership.xml
X0508
4
2023-11-09
0
0001580149
BIOVIE INC.
BIVI
0001168218
ROGICH SIGMUND
C/O BIOVIE INC.
680 W NYE LANE STE 201
CARSON CITY
NV
89703
1
0
0
0
0
Common Stock
2023-11-09
4
A
0
42254
0
A
42254
D
The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on September 22, 2023, subject to board approval, which was obtained on November 9, 2023. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting.
/S/ SIGMUND ROGICH
2023-12-05